Rezolute Inc (RZLT NASDAQ) stock market data APIs
$7.4243
0.3(4%)
as of September 15, 2025
Try our APIs with
free plan!
Rezolute Inc Financial Data Overview
Price chart is built with
Anychart
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. The company's lead product candidate is ersodetug, a human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 2 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.
Prev. Close
7.4243
Open
7.7284
High
7.8322
Low
7.2559
52 wk Range
2.215-8.335
Market Cap
650 M
Shares Outstanding
86 996 K
EPS
0
Beta
0.033
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Rezolute Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Rezolute Inc data using free add-ons & libraries
Get Rezolute Inc Fundamental Data
Rezolute Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -77 116 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-09-11
- EPS/Forecast: -0.2133
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Rezolute Inc News
New
Rezolute Hits 52-Week High On Ersodetug Progress In UpLIFT And SunRIZE Trials For Hyperinsulinism
(RTTNews) - Shares of Rezolute Inc. (RZLT) touched a new 52-week high of $8.06 last week amid FDA alignment on a significantly streamlined clinical development path for its lead asset, Ersodetug, in t...
Rezolute to Participate in Upcoming Investor Conferences
REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused...
Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer
REDWOOD CITY, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused...
Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer
Rezolute, Inc. Experienced commercial and biopharmaceuticals leader to spearhead launch strategy and global market readiness for ersodetug REDWOOD CITY, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Rez...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
